Speclipse, Inc., is the medical device developer of the world’s first cancer diagnostic solution based on laser-induced plasma spectroscopy (LIPS) and artificial intelligence (AI) technology. Our core technology, Spectra-Scope®, embodies a real-time, non-invasive, in-vivo diagnosis of skin cancers without compromising efficacy and accuracy while preventing unnecessary biopsies. We are committed to providing innovative medical technology to assist in challenging diagnosis cases—and it is our mission to continue to improve our technology so physicians can spend more time focusing on their patients and making accurate diagnoses.
| Website | http://www.speclipse.com |
| Employees | 9 (4 on RocketReach) |
| Founded | 2015 |
| Address | 310 De Guigne Dr, Sunnyvale, California 94085, US |
| Phone | +82 31-698-2269 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+6 more
(view full list)
|
| Industry | Medical Devices, Health Care, Diagnostic Equipment, Health Diagnostics, Therapeutic Devices |
| Keywords | Cancer Diagnostics, Cancer Detection, Medical Devices, Cancer Research, Medical Diagnostics, Medical Technology, Healthcare Technology, Laser Spectroscopy, Disease Diagnostics, Artificial Intelligence, Health Diagnostics, Ai In Healthcare, Diagnostic Tools, Oncology Technology, Medical Imaging, Data Analytics, Precision Medicine, Biomedical Engineering |
| Competitors | SAS, IBM, Snowflake, Verisk Financial, Alteryx, Tableau, Domo, Qlik, Looker, MicroStrategy Italy +38 more (view full list) |
Looking for a particular Speclipse, Inc. employee's phone or email?
Sung Pyun is the Founder and CEO of Speclipse, Inc..
4 people are employed at Speclipse, Inc..
Speclipse, Inc. is based in Sunnyvale, California.